References
Bohn H.: Nachweis und Charakterisierung von Schwangerschaftsproteinen in der menschlichen Plazenta, sowie ihre quantitative immunologische Bestimmung im Serum schwangerer Frauen — Arch. Gynäk.210, 440, 1971.
Bohn H.: Nachweis und Charakterisierung von löslichen Antigenen in der menschlichen Plazenta — Arch. Gynäk.212, 165, 1972.
Bohn H.: Isolierung des Plazentaproteins PP2 und seine Identifizierung als Ferritin — Arch. Gynäk.215, 263, 1973.
Bohn H.: Detection, characterization and diagnostic significance of human pregnancy-associated glycoproteins — Blut26, 205, 1973.
Bohn H.: Immunochemical determinations of human pregnancy proteins — Arch. Gynäk.217, 219, 1974.
Bohn H.: Isolierung und Charakterisierung eines hochmolekulären Plazentaproteins (PP6). Arch. Gynäk.218, 331, 1975.
Bohn H.: Placental and pregnancy proteins. In:Lehmann F. G. (Ed.): Carcino-embryonic proteins. Elsevier/North Holland Biomedical Press, Amsterdam, 1979; vol. I, p. 289.
Bohn H.: Isolation and characterization of two soluble placental tissue proteins (PP8 and PP10). In:Peeters H. H. (Ed.): Protides of the biological fluids. 27th Colloquium. Pergamon Press, Oxford-New York, 1979; p. 879.
Bohn H., Inaba N., Lüben G.: New placental proteins and their potential diagnostic significance as tumour markers — Oncodevelop. Biol. Med.2, 141, 1981.
Bohn H., Johannsen R., Kraus W.: Neues Plazentaprotein (PP15) mit immunsuppressiver Wirkung — Arch. Gynec.230, 167, 1980.
Bohn H., Kraus W.: Isolierung und Charakterisierung des Plazentaproteins PP1 — Arch. Gynäk.221, 73, 1976.
Bohn H., Kraus W.: Isolierung und Charakterisierung eines neuen plazentaspezifischen Proteins (PP10) — Arch. Gynäk.227, 125, 1979.
Bohn H., Kraus W.: Isolierung und Charakterisierung eines neuen plazentaspezifischen Proteins (PP12) — Arch. Gynec.229, 279, 1980.
Bohn H., Kraus W., Winckler W.: New soluble placental tissue proteins: their isolation, characterization, localization and quantitation — Placenta (Suppl. 4), 1982. (In press).
Bohn H., Winckler W.: Isolierung und Charakterisierung eines neuen Gewebsproteins (PP7) aus menschlichen Plazenten — Arch. Gynäk.222, 5, 1977.
Bohn H., Winckler W.: Isolierung und Charakterisierung des Plazentaproteins PP5 — Arch. Gynäk.223, 179, 1977.
Bohn H., Winckler W.: Isolierung und Charakterisierung eines neuen Plazenta-Gewebsproteins (PP11) — Arch. Gynec.229, 293, 1980.
Gordon Y. B., Grudzinskas J. G., Jeffrey D., Letchworth A. T., Chard T.: Concentrations of pregnancy-specific β1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation — Lanceti, 331, 1977.
Grudzinskas J. G., Gordon Y. B., Jeffrey D., Chard T.: Specific and sensitive determination of pregnancy-specific β1-glycoprotein (SP1) by radioimmunoassay: a new pregnancy test — Lanceti, 333, 1977.
Horne C. H. W., Towler C. M., Pugh-Humphreys R. G. P., Thomson A. W., Bohn H.: Pregnancy-specific β1-glycoprotein — a product of the syncytiotrophoblast — Experientia (Basel)32, 1197, 1976.
Inaba N., Renk T., Bohn H.: Immunohistochemical location of new placental proteins (PP8, PP9, PP10, PP11, PP12) in human term placentae — Arch. Gynec.230, 109, 1980.
Inaba N., Renk T., Ax W., Schottler S., Weinmann E., Bohn H.: Possible synthesis of pregnancy-‘specific’ β1-glycoprotein (SP1) and placenta-‘specific’ tissue proteins (PP10 and PP12) by human and cynomolgus monkey leukocytes — Acta haemat. (Basel)66, 35, 1981.
Jandial V., Towler C. M., Horne C. H. W., Abramovich D. R.: Plasma pregnancy-specific β1-glycoprotein in complications of early pregnancy — Brit. J. Obstet. Gynaec.85, 832, 1978.
Lin T. M., Halbert S. P., Kiefer D., Spellacy W. N., Gall S.: Characterization of four human pregnancy-associated plasma proteins — Amer. J. Obstet. Gynec.118, 223, 1974.
Lüben G., Schütze D., Bohn H.: Circulating levels of placental proteins PP7 and PP8 in various cancer conditions. In:Peeters H. H. (Ed.): Protides of the biological fluids. 27th Colloquium. Pergamon Press, Oxford-New York, 1979; p. 253.
Marcus C. J., Habig W. H., Jacoby W. B.: Glutathione transferase from human erythrocytes — Arch. Biochem.188, 287, 1978.
Nisbet A. D., Bremner R. D., Herriot R., Jandial V., Horne C. H. W., Bohn H.: Placental protein 5 (PP5): development of a radioimmunoassay and measurement of circulating levels in normal pregnancy — Brit. J. Obstet. Gynaec.88, 484, 1981.
Obiekwe B. C., Pendlebury D. J., Gordon Y. B., Grudzinskas J. G., Chard T., Bohn H.: The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancy — Clin. chim. Acta95, 509, 1979.
Petrunin D. D., Gryaznova I. M., Petrunina Yu. A., Tatarinov Yu. S.: Comparative immunochemical and physicochemical characteristics of human chorionic α1-and α2-microglobulins — Byull. éksp. Biol. Med.5, 600, 1978.
Petrunin D. D., Kozljaeva G. A., Mesnjankina N. V., Shevchenko O. P.: Detection of chorionic α2-microglobulin in the endometrium in the secretory phase of the menstrual cycle and in the male sperm — Akush. i Ginek.3, 22, 1980.
Ranta T., Shteri J. E., Koistinen R., Salem H. T., Bohn H., Koskimies A. I., Seppälä M.: Human seminal plasma contains placental protein 5 (PP5)-like immunoreactive substance that shares physicochemical properties with PP5 from placenta — J. clin. Endocr.53, 1087, 1981.
Salem H. T., Lee J.-N., Seppälä M., Vaara L., Aula P., Al-Ani A. T. M., Chard T.: Measurement of placental protein 5, placental lactogen and pregnancy-specific β1-glycoprotein in mid-trimester as a predictor of outcome of pregnancy — Brit. J. Obstet. Gynaec.88, 371, 1981.
Salem H. T., Obiekwe B. C., Al-Ani A. T. M., Seppälä M., Chard T.: Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer — Clin. chim. Acta107, 211, 1980.
Sedlacek H. H., Rehkopf R., Bohn H.: Immunofluorescence histological localisation of human pregnancy and placenta proteins in the placenta of man and monkey (cynomolgus) — Behring Inst.-Mitteil.69, 81, 1976.
Seppälä M., Rutanen E.-M., Heikinheimo M., Jalanko H., Engvall E.: Detection of trophoblastic tumour activity by pregnancy-specific β1-glycoprotein — Int. J. Cancer21, 265, 1978.
Seppälä M., Tönnberg L., Ylöstalo P., Jouppila P.: Early detection of implantation by pregnancy-specific beta-1-glycoprotein secretion in an infertile woman treated by artificial insemination and human chorionic gonadotropin — Fertil. and Steril.32, 604, 1979.
Seppälä M., Wahlström T., Bohn H.: Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast — Int. J. Cancer24, 6, 1979.
Tatarinov Yu. S.: Trophoblast-specific β1-glycoprotein as a marker for pregnancy and malignancies — Gynec. obstet. Invest.9, 65, 1978.
Tatarinov Yu. S., Sokolov A. V.: Development of a radioimmunoassay for pregnancy-specific β1-globulin and its measurement in serum of patients with trophoblastic and non-trophoblastic tumours — Int. J. Cancer19, 161, 1977.
Towler C. M., Jandial V., Bohn H.: A serial study of pregnancy proteins in primigravidae — Brit. J. Obstet. Gynaec.83, 368, 1976.
Würz H., Lüben G., Bohn H., Künzig H. J., Geiger W.: Radioimmunological determination of two new placental proteins (PP10 and PP12) during normal and pathological pregnancies — Placenta 1981. (In press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bohn, H. New soluble placental tissue proteins. La Ricerca Clin. Lab. 12, 221–230 (1982). https://doi.org/10.1007/BF02909329
Issue Date:
DOI: https://doi.org/10.1007/BF02909329